What is G6PD Deficiency Drug Risk?
▾
Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency is the most common human enzyme deficiency, affecting approximately 400 million people worldwide, predominantly males due to its X-linked recessive inheritance pattern. G6PD is essential for the pentose phosphate pathway, which generates NADPH — the primary antioxidant defence inside red blood cells. Without adequate G6PD activity, red blood cells cannot neutralise reactive oxygen species (ROS) generated by oxidative stress from drugs, infections, or certain foods. This leads to oxidative damage of haemoglobin and the red cell membrane, forming Heinz bodies (denatured haemoglobin aggregates) that are recognised and removed by the spleen, causing haemolytic anaemia. The WHO classifies G6PD deficiency into five classes based on the degree of enzyme deficiency and clinical severity: Class I (severe deficiency with chronic non-spherocytic haemolytic anaemia), Class II (severe deficiency, <10% residual activity, intermittent acute haemolysis), Class III (moderate deficiency, 10–60% activity, haemolysis only with triggers), Class IV (mildly reduced or normal activity, clinically insignificant), and Class V (increased enzyme activity). The G6PD haemolysis risk calculator helps clinicians assess the likelihood of acute haemolysis based on a patient's known G6PD status and exposure to oxidative drugs or foods. The most common variants include G6PD A- (Africa), G6PD Mediterranean (Middle East and southern Europe), G6PD Canton (Southeast Asia), and G6PD Mahidol (Myanmar and Thailand).
DigiCalcs delivers precision-engineered tools for engineers and STEM professionals.
Formula
▾
Risk classification by WHO enzyme activity class: Class I (<1% activity) = Chronic haemolysis even without triggers; Class II (1-10%) = High risk with oxidative stress; Class III (10-60%) = Moderate risk, triggered by specific drugs/foods; Class IV (60-150%) = Normal, no clinical risk; Class V (>150%) = No risk; High-risk triggers: Primaquine, Dapsone, Rasburicase, Fava beans, Methylene blue, Nitrofurantoin; Haemolysis severity ∝ Residual enzyme activity × Oxidant dose × Duration of exposure; Hemoglobin drop monitoring: Check Hb at 24h, 48h, 72h post-exposureVariable Legend
▾
| Symbol | Name | Unit | Description |
|---|---|---|---|
| NADPH | Nicotinamide Adenine Dinucleotide Phosphate (reduced) | — | Key antioxidant cofactor produced by G6PD in red blood cells |
| ROS | Reactive Oxygen Species | — | Oxidant molecules that damage haemoglobin and red cell membranes when NADPH is deficient |
How to G6PD Deficiency Drug Risk
▾
- 1Confirm G6PD deficiency status through enzyme activity assay (fluorescent spot test or quantitative spectrophotometry).
- 2Classify the deficiency severity using WHO Class I–V based on residual enzyme activity and clinical history.
- 3Assess current exposure to known oxidative triggers: drugs (dapsone, primaquine, rasburicase, high-dose aspirin, nitrofurantoin, phenazopyridine), infections, or fava beans (favism).
- 4Evaluate haematological parameters: haemoglobin drop, reticulocyte count, LDH, bilirubin, and peripheral blood film for Heinz bodies and bite cells.
- 5Determine haemolysis risk level: low (Class IV/V, no exposure), moderate (Class III with mild oxidative trigger), or high (Class I/II with strong oxidative trigger).
- 6For high-risk situations, stop the offending agent, ensure adequate hydration, monitor for haemoglobinuria (dark urine), and assess need for blood transfusion.
- 7Provide patient education on drugs and foods to avoid long-term.
Worked Examples
▾
G6PD Mediterranean has <10% residual activity — very sensitive to primaquine
Class II G6PD deficiency with primaquine (an 8-aminoquinoline with strong oxidant potential) creates very high risk of acute haemolytic crisis.
Rasburicase generates H2O2 as a byproduct of uric acid metabolism
Rasburicase is contraindicated in all grades of G6PD deficiency. Use allopurinol or febuxostat instead for uric acid lowering.
Nitrofurantoin is on the avoid list for G6PD-deficient patients
Moderate G6PD deficiency with a mild-moderate oxidant drug warrants avoiding the drug and selecting a safer alternative.
Avoid aspirin (salicylates) in G6PD deficiency at high doses
Paracetamol is generally safe in G6PD deficiency at therapeutic doses. Aspirin at high doses (anti-inflammatory doses) should be avoided.
Real-World Applications
▾
Mortgage lenders and loan officers use G6Pd Haemolysis Risk to structure repayment schedules, compare fixed versus adjustable rate options, and calculate total borrowing costs for residential and commercial real estate transactions across different term lengths.
Personal finance advisors apply G6Pd Haemolysis Risk when counseling clients on debt reduction strategies, comparing the mathematical benefit of accelerated payments against alternative investment returns to determine the optimal allocation of surplus cash flow.
Corporate treasury departments use G6Pd Haemolysis Risk to model the cost of revolving credit facilities, term loans, and commercial paper programs, optimizing the company's capital structure and minimizing weighted average cost of debt financing.
Special Cases
▾
Zero or negative interest rate
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in g6pd haemolysis risk calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Balloon payment at maturity
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in g6pd haemolysis risk calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Variable rate mid-term adjustment
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in g6pd haemolysis risk calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
Methylene Blue Contraindication
Methylene blue, used to treat methaemoglobinaemia, works through NADPH-dependent pathways. In G6PD-deficient patients, methylene blue is ineffective and can worsen haemolysis. Alternative treatments (ascorbic acid, exchange transfusion) should be used for methaemoglobinaemia in these patients.
WHO Classification of G6PD Deficiency
▾
| WHO Class | Enzyme Activity | Clinical Presentation | Common Variants |
|---|---|---|---|
| I | <1% (severe) | Chronic non-spherocytic haemolytic anaemia | G6PD Canton, G6PD Tripler |
| II | <10% (severe) | Acute haemolysis with oxidant exposure | G6PD Mediterranean, G6PD A- |
| III | 10–60% (moderate) | Haemolysis only with significant triggers | G6PD A-, G6PD Seattle |
| IV | 60–150% (normal) | Clinically insignificant | G6PD B (wildtype) |
| V | >150% (increased) | No haemolysis; enzyme overactivity | Rare variants |
Frequently Asked Questions
▾
Why are males more commonly affected by G6PD deficiency?
G6PD is encoded on the X chromosome. Males have only one X chromosome, so a single defective copy causes deficiency. Females have two X chromosomes and typically need both to be deficient (or to be very unfavourably lyonised) to exhibit significant symptoms, making them mostly carriers with variable enzyme activity.
What is favism?
Favism is acute haemolytic anaemia triggered by ingestion of fava beans (broad beans) in G6PD-deficient individuals. It is most common in the Mediterranean variant (Class II). The oxidants vicine and convicine in fava beans overwhelm the deficient antioxidant system. Even inhalation of fava bean pollen can trigger crisis in very sensitive individuals.
How is G6PD deficiency diagnosed?
The WHO fluorescent spot test is the most widely used screening method: normal G6PD generates NADPH which fluoresces under UV light; a negative (non-fluorescent) spot indicates deficiency. Quantitative spectrophotometric assay measures actual enzyme activity and is used for confirmation and classification. Results must be interpreted carefully during or shortly after a haemolytic episode, when reticulocytosis can give falsely normal results.
What are the common triggers for G6PD haemolysis?
Common triggers for G6PD haemolysis include certain medications such as primaquine, which can cause haemolysis in approximately 10-20% of individuals with G6PD deficiency, and certain foods like fava beans. Infections, like bacterial or viral infections, can also trigger haemolysis in about 50-60% of cases. Additionally, exposure to certain chemicals or stress can precipitate haemolysis in individuals with G6PD deficiency.
How does the severity of G6PD deficiency impact haemolysis risk?
The severity of G6PD deficiency, which is classified into five classes based on enzyme activity levels, impacts haemolysis risk. For example, individuals with class I deficiency, which has less than 10% of normal enzyme activity, are at higher risk of severe haemolysis compared to those with class III deficiency, who have 10-60% of normal enzyme activity. Generally, individuals with enzyme activity levels below 20% are at increased risk of haemolysis, while those with levels above 60% are usually asymptomatic.
Common Mistakes to Avoid
▾
- !Prescribing rasburicase for tumour lysis syndrome without screening for G6PD deficiency — it is absolutely contraindicated.
- !Testing G6PD activity during an acute haemolytic episode, which gives falsely normal results due to selective destruction of deficient cells.
- !Assuming female carriers have normal G6PD activity — extreme lyonisation can lead to significant deficiency in females.
- !Using high-dose aspirin (anti-inflammatory doses) in G6PD-deficient patients — safe at analgesic doses only.
- !Overlooking neonatal jaundice risk in G6PD-deficient newborns, where bilirubin can rise rapidly enough to cause kernicterus.
- !Not counselling patients with G6PD deficiency about fava beans and over-the-counter drugs that contain oxidant compounds.
Pro Tip
Carry a G6PD drug safety card. Many pharmacies and travel clinics can provide lists of safe and unsafe medications. Apps such as G6PD Deficiency Drug List provide real-time lookups of drug safety in G6PD deficiency.
Did you know?
The geographic distribution of G6PD deficiency maps almost perfectly onto the historical range of malaria. The Sardinian population has one of the highest G6PD deficiency rates in Europe (up to 35% of males), corresponding to Sardinia's historically high malaria burden before the WHO eradication programme of the 1950s.
References
Have a question about this calculator? Get a detailed answer.
Get Weekly Math Tips
Join 12,000+ subscribers who get calculator tips every week.